Today’s Deals – GV co-leads $27.1M Series A in Oxford Uni life sciences spinout Vaccitech Thomas Crown Companies January 15, 2018Deals, Funding 0 Comment Leaning on its in-house life sciences expertise GV has backed another biotech startup in the UK, co-leading a £20 million ($27.1M) Series A in Oxford University spinout Vaccitech, which is developing a universal flu vaccine. Read More from TechCrunch Share this:PinterestFacebookTwitterRedditMoreTumblrLike this:Like Loading... Related